Transition begins after Pfizer-Pharmacia merger

New York-Pfizer Inc. will invest $400 million to expand its New Jersey facilities and potentially add 1,300 jobs, but plans to close five research and development sites around the world-including two in the United States- and other former Pharmacia Corp. offices as it begins the difficult logistical transition of its $57 billion takeover.

Related Content:

UrologyPediatrics

The National Center for Children’s Vision and Eye Health at Prevent Blindness forges Children’s Vision Equity Alliance

Study finds optic nerve pallor prevalent in ZIKA virus patients

Corneal neurotization is effective for restoring sensory innervation